Why Didn’t the U.S. Detect Omicron Cases Sooner?
How the U.S. has addressed genomic sequencing research played a large role in the country’s ability to to track the evolution of COVID-19.
Read MorePosted by Andy Lundin | Dec 6, 2021 | Covid 19, Molecular Diagnostics |
How the U.S. has addressed genomic sequencing research played a large role in the country’s ability to to track the evolution of COVID-19.
Read MorePosted by Andy Lundin | Dec 3, 2021 | Covid 19, Rapid Assays |
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
President Biden is developing a winter pandemic plan that includes providing reimbursement for those conducting at-home coronavirus tests.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
BD published a statement clarifying the efficacy of its rapid antigen and PCR tests to monitor for the COVID-19 Omicron variant.
Read MorePosted by Andy Lundin | Dec 2, 2021 | Covid 19, Immunoassay Reagents & test Kits |
Hologic designed its assays with the expectation that SARS-CoV-2 would continue to evolve, which is the natural path for viruses.
Read More